share_log

Nanalysis to Present at the Planet MicroCap Showcase 2022 in Las Vegas on Wednesday, May 4, 2022

Accesswire ·  May 2, 2022 08:35

CALGARY, AB / ACCESSWIRE / May 2, 2022 / Nanalysis Scientific Corp. ("the Company"), (TSXV:NSCI)(OTCQX:NSCIF)(FRA:1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, today announced that it will be presenting at the Planet MicroCap Showcase 2022 at the Bally's Hotel & Casino in Las Vegas, NV on Wednesday, May 4, 2022 at 5:30 PM Pacific Time. Sean Krakiwsky, CEO of Nanalysis will be hosting the presentation and answering questions from investors, as well as, in person, 1-on-1 investor meetings over two days.

To access the live presentation, please use the following information:

Planet MicroCap Showcase 2022 in Las Vegas

Date: Wednesday, May 4, 2022
Time: 5:30 PM Pacific Time
Webcast:

If you would like to book 1on1 investor meetings with Mr. Krakiwsky and to attend the Planet MicroCap Showcase 2022, please make sure you are registered here:

1on1 meetings will be scheduled and conducted in person at the conference venue.

The Planet MicroCap Showcase 2022 website is available here:

If you can't make the live presentation, all company presentations "webcasts" will be available directly on the conference event platform on this link under the tab "Agenda":

News Compliments of Accesswire

About Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1)

Nanalysis trades on the TSX Venture Exchange (TSXV) in Canada with ticker symbol 'NSCI', OTC and the Frankfurt exchange under the ticker symbol '1N1'. The company's business is what we term "MRI and NMR for industry". The company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The company has followed-up that initial offering with new products and continues to have a strong innovation pipeline. Nanalysis recently announced that it has begun selling a 100MHz device in 2020. The Company's new device will be the most powerful and most advanced compact NMR device ever brought to market.

Nanalysis devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company continues to exploit new global market opportunities independently and with partners.

With the recent acquisition of K'Prime, the company maintains a North American sales and service company of over 40 individuals who cover scientific instrumentation for pharma, food, chemical and oil & gas customers, as well as imaging systems for security applications.

Additionally, the Company has a 43% ownership in Quad Systems AG ("Quad Systems"), with an option to purchase the remaining shares. Quad Systems is a Zurich-based Nuclear Magnetic Resonance (NMR) company focused on high-field NMR for pharmaceutical and other vertical markets.

About SNN.Network

SNN.Network is your multimedia financial news platform for discovery, transparency and due diligence. This is your one-stop hub to find new investment ideas, check in on watchlist, gather the most up-to-date information on the Small-, Micro-, Nano-Cap market with the goal to help you towards achieving your wealth generation goals. Follow the companies YOU want to know more about; read and watch content from YOUR favorite finance and investing influencers; create YOUR own watchlist and screen for ideas YOU'RE interested in; find out about investor conferences YOU want to attend - all here on SNN.Network.

If you would like to attend the Planet MicroCap Showcase, please register here:

Contact:

Matthew Selinger
Firm IR Group
415-572-8152
mselinger@firmirgroup.com

SOURCE: Nanalysis Scientific via SNN Network


View source version on accesswire.com:
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment